120 related articles for article (PubMed ID: 6192293)
21. [Effects of intraventricular injection of 5,7-dihydroxytryptamine on monoamines and sleep in the kitten (author's transl)].
Adrien J; Bourgoin S; Laguzzi R; Hamon M
J Physiol (Paris); 1981; 77(2-3):425-30. PubMed ID: 7288656
[TBL] [Abstract][Full Text] [Related]
22. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
Mueller RA; Towle A; Breese GR
Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
[TBL] [Abstract][Full Text] [Related]
23. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
Rodríguez FD; Rodríguez RE
Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
[TBL] [Abstract][Full Text] [Related]
24. Regeneration of normal terminal innervation patterns by central noradrenergic neurons after 5,7-dihydroxytryptamine-induced axotomy in the adult rat.
Björklund A; Lindvall O
Brain Res; 1979 Aug; 171(2):271-93. PubMed ID: 466444
[TBL] [Abstract][Full Text] [Related]
25. Noradrenaline and dopamine interaction in rat brain during development.
Ponzio F; Hallman H; Jonsson G
Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
[TBL] [Abstract][Full Text] [Related]
26. [Morphological changes in the neurons of the rat nucleus raphe dorsalis following application of 5,7-dihydroxytryptamine. A golgi-rapid-impregnation study].
Hölzel B; Pfister C; Fink H
J Hirnforsch; 1984; 25(3):343-9. PubMed ID: 6206129
[TBL] [Abstract][Full Text] [Related]
27. Effects of morphine on the 6-hydroxydopamine induced changes of the postnatal development of central noradrenaline neurons.
Jonsson G; Hallman H
Med Biol; 1982 Aug; 60(4):191-8. PubMed ID: 6128445
[TBL] [Abstract][Full Text] [Related]
28. Long-lasting depletion of spinal cord 5-hydroxytryptamine or catecholamines after intraspinal injection of 5,7-dihydroxytryptamine or 6-hydroxydopamine to newborn rats.
Carruba MO; Keller HH; Da Prada M
Neurosci Lett; 1983 Feb; 35(2):173-8. PubMed ID: 6190112
[No Abstract] [Full Text] [Related]
29. Quantitative effects of a neurotoxin upon serotonin levels within tissue compartments of the medicinal leech.
Lent CM
J Neurobiol; 1984 Sep; 15(5):309-23. PubMed ID: 6502156
[TBL] [Abstract][Full Text] [Related]
30. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
[TBL] [Abstract][Full Text] [Related]
31. Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacologic agents in adult and developing rats.
Breese GR; Mueller RA
Ann N Y Acad Sci; 1978 Jun; 305():160-74. PubMed ID: 280248
[No Abstract] [Full Text] [Related]
32. Developmental alterations in 5-hydroxytryptamine concentration and turnover after treatment of neonatal rats with 5,7-dihydroxytryptamine.
Mercugliano M; Nguyen H; Djali S; Lucki I
Neurobiol Learn Mem; 1996 Mar; 65(2):163-76. PubMed ID: 8833105
[TBL] [Abstract][Full Text] [Related]
33. In vivo binding properties of [carbonyl-11C]WAY-100635: effect of endogenous serotonin.
Maeda J; Suhara T; Ogawa M; Okauchi T; Kawabe K; Zhang MR; Semba J; Suzuki K
Synapse; 2001 May; 40(2):122-9. PubMed ID: 11252023
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
Saller CF; Stricker EM
Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
[No Abstract] [Full Text] [Related]
35. In vivo-synthesized radioactively labelled alpha-methyl serotonin as a selective tracer for visualization of brain serotonin neurons.
Cohen Z; Tsuiki K; Takada A; Beaudet A; Diksic M; Hamel E
Synapse; 1995 Sep; 21(1):21-8. PubMed ID: 8525458
[TBL] [Abstract][Full Text] [Related]
36. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
[TBL] [Abstract][Full Text] [Related]
37. [Anxiety-like behavior in rats neonatally and adultly treated with 5,7-dihydroxytryptamine].
Yamada I; Iwasaki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):145-51. PubMed ID: 12451684
[TBL] [Abstract][Full Text] [Related]
38. Alteration of aminophylline-induced respiratory stimulation by perturbation of biogenic amine systems.
Mueller RA; Lundberg DB; Breese GR
J Pharmacol Exp Ther; 1981 Sep; 218(3):593-9. PubMed ID: 7264947
[TBL] [Abstract][Full Text] [Related]
39. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
Kirby ML; Mattio TG
Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
[TBL] [Abstract][Full Text] [Related]
40. Age-dependent effects of 5,7-dihydroxytryptamine on serotonin transporter in different brain areas in the rat.
Kostowski W; Bidziński A; Krzaścik P; Szyndler J; Rok P; Kołomańska P; Wisłowska A; Lehner M; Płaźnik A
Pol J Pharmacol; 2004; 56(4):383-9. PubMed ID: 15520491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
